Due to the characteristic of adiponectin/leptin ratio in obesity in general, there is strong possibility that the ratio would also serve as an excellent marker for pancreatic cancer, similar to IL-6/IL-8 ratio, for tracking inflammation for clinical purposes. The gene discussed is CXCL8; the disease is familial pancreatic carcinoma.